| |
| |
|
| Insider
Information: |
Emster Kurt Von |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
302,614 |
|
|
Indirect Shares
|
18,297,697 |
|
|
| Direct
Value |
$5,586,634 |
|
|
|
Indirect Value
|
$163,000,549 |
|
|
| Total
Shares |
18,600,311 |
|
|
| Total
Value |
$168,587,184 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
173,611 |
2004-02-19 |
4,350,516 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2018-06-05 |
90,000 |
2018-12-18 |
1,171,268 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-09-29 |
18,406 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
Director |
2020-06-16 |
0 |
2020-06-16 |
4,168,718 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-17 |
17,828 |
2021-05-18 |
2,960,231 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-04-13 |
21,175 |
2021-09-24 |
5,628,558 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
|
– • – |
2024-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(90,000) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-09-29 |
4 |
AS |
$15.68 |
$249,675 |
D/D |
(15,921) |
90,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-09-29 |
4 |
OE |
$5.00 |
$79,605 |
D/D |
15,921 |
105,921 |
0 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-04-13 |
4 |
S |
$1.49 |
$13,524 |
D/D |
(9,075) |
21,175 |
0 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2022-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
30,250 |
30,250 |
0 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • • |
2021-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,628,558 |
|
% |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2021-05-18 |
4 |
B |
$11.00 |
$8,499,997 |
I/I |
772,727 |
2,960,231 |
2.1 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,187,504 |
2,187,504 |
0 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2021-05-17 |
4 |
B |
$12.04 |
$214,656 |
D/D |
17,828 |
17,828 |
2.39 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Director |
– • – |
2020-06-16 |
4 |
B |
$16.00 |
$200,000 |
I/I |
12,500 |
4,168,718 |
2.1 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
4,156,218 |
4,156,218 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-12-18 |
4/A |
S |
$29.70 |
$1,869,168 |
I/I |
(62,925) |
1,171,268 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-12-18 |
4 |
S |
$29.70 |
$2,077,101 |
I/I |
(69,925) |
1,164,268 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-12-18 |
4 |
S |
$7.43 |
$397,365 |
I/I |
(53,492) |
131,036 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-12-17 |
4 |
S |
$8.17 |
$726,223 |
I/I |
(88,889) |
184,528 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-12-17 |
4 |
S |
$33.17 |
$99,797 |
I/I |
(3,009) |
1,234,193 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-05-14 |
4 |
S |
$52.20 |
$22,142,556 |
I/I |
(400,000) |
1,237,202 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-05-11 |
4 |
S |
$51.73 |
$13,209,900 |
I/I |
(250,000) |
1,637,202 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-03-05 |
4 |
AS |
$15.51 |
$207,105 |
I/I |
(13,353) |
273,417 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-02-15 |
4 |
AS |
$14.49 |
$995,637 |
I/I |
(68,712) |
286,770 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-02-14 |
4 |
AS |
$16.69 |
$2,720,120 |
I/I |
(162,979) |
355,482 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
